News & Articles

Genomic analysis tools SIRIUS and MERCURY to be implemented into the Google Cloud Platform

Fully-automated BD Phoenix™ CPO Detect Test Receives U.S. FDA Clearance

Anti-Müllerian assay kit, MenoCheck, will help prevent complications associated with the onset on menopause

Expert in mass spectrometry for therapeutic drug monitoring shares research goals and future predictions

We interview a scientist whose team designed AAV vectors used in a successful gene therapy clinical trial, and highlight the key technologies that supported his efforts

Five color, high-performance immunohistochemistry multiplexing solution to advance biomarker studies

Lactate Scout 4 designed for use in the field as training companion for individuals and sports teams

Contract researchers and cancer biologists, Robert B. Harris, Ph.D., Thomas Reynolds, and Gregory A. Meyers, owners and founders of NEXT Molecular Analytics, have joined the DNA sequencing revolution. To keep up their research momentum, they consider a next big step — automation

Olympus AI algorithm could improve clinical pathology classifications

HeartMate 3 offers significant advancements for patients not eligible for a heart transplant

Findings reported at ASHG 2018 annual meeting describe new associations between environmental factors and pharmacogenes

Ready-to-use kits determine genomic characteristics of solid tumours

The GDN brings together leading diagnostics services providers to share expertise and drive worldwide diagnostics innovation

In vitro diagnostic device designed for dried blood spot analysis

MR Solutions displays latest PET-MRI system at WMIC

From 3D tissue profiling to intelligent surgical tools, discover some of the latest innovations set to revolutionize diagnostics in cancer

This intelligent surgical device is a cornerstone in the surgical removal of cancers

Quantifying and targeting MDSCs, the ‘queen bee of the TME’, could overcome resistance to immunotherapy, Dr. R. J. Tesi tells SelectScience

Hydrogen peroxide-sensing molecule reveals whether chemotherapy drugs are having their intended effects

Research shows adding Abbott's High Sensitive Troponin-I diagnostic test to doctors' existing standard of care can help more accurately determine a person's chances of a heart attack or other cardiac event potentially months to years in advance

New liquid biopsy test can identify 70 of the most commonly mutated genes in solid tumours, as well as microsatellite instability

Ground-breaking technology unlocks rapid and simple label-free 3D and 4D live cell imaging